Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia

BACKGROUND: Pretreatment platelet count has been reported as a potential tool to predict survival outcome in several solid tumors. However, the predictive value of pretreatment platelet count remains obscure in de novo acute myeloid leukemia (AML) excluding acute promyelocytic leukemia (M3). METHODS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PeerJ
Main Authors: Zhang, Qianying, Dai, Kanchun, Bi, Laixi, Jiang, Songfu, Han, Yixiang, Yu, Kang, Zhang, Shenghui
Format: Artigo
Jezik:Inglês
Izdano: PeerJ Inc. 2017
Teme:
Hematology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5742276/
https://ncbi.nlm.nih.gov/pubmed/29302387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.4139
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki